V V Sherstnev Selected Research

Proteins (Proteins, Gene)

3/2015	Molecular markers of arterial hypertension in patients with normotony, pre-hypertension and hypertension.
2/2014	Content of S100b protein, HLDF24 peptide and autoantibodies to these factors as potential biomarkers for arterial hypertension in blood serum of healthy people.
9/2012	Involvement of HLDF protein and anti-HLDF antibodies in the mechanisms of blood pressure regulation in healthy individuals and patients with stable hypertension and hypertensive crisis.
7/2011	[Serum immunoboichemical markers in patients suffered with hypertension-induced cerebrovascular diseases].
11/2007	Effects of protein synthesis inhibitors during reactivation of associative memory in the common snail induces reversible and irreversible amnesia.
9/2006	[Inhibition of protein synthesis during associative memory reactivation produces reversible or irreversible amnesia in the snail Helix lucorum].
1/2006	[The peculiarities of serum levels of S100b protein and antibodies to it in patients with crisis and stable essential hypertension].
1/2004	[Protein HLDF and antibodies to it as molecular pathogenetic factors and new markers of acute cerebral blood circulation disturbances].
1/2002	[Neurotrophic factors and autoantibodies to them as molecular predictors of cerebral dysfunctions].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V V Sherstnev Research Topics

Disease

4	Alzheimer Disease (Alzheimer's Disease) 07/2017 - 01/2004
4	Hypertension (High Blood Pressure) 03/2015 - 07/2011
3	Hypertensive Crisis 09/2012 - 01/2004
3	Amnesia (Dissociative Amnesia) 01/2011 - 09/2006
2	Stroke (Strokes) 07/2017 - 01/2005
2	Ischemia 07/2017 - 03/2007
2	Essential Hypertension 09/2012 - 01/2006
2	Leukemia 09/2012 - 07/2006
2	Brain Ischemia (Cerebral Ischemia) 03/2007 - 01/2002
1	Prehypertension 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2011
1	Brain Injuries (Brain Injury) 03/2007
1	Cognitive Dysfunction 01/2006
1	Brain Diseases (Brain Disorder) 01/2006
1	Thrombosis (Thrombus) 01/2005
1	Cryoglobulinemia 01/2005
1	Ischemic Stroke 01/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2002
7	Peptides (Polypeptides)IBA 01/2020 - 01/2004
6	AntibodiesIBA 09/2012 - 01/2004
4	AutoantibodiesIBA 01/2020 - 01/2002
3	threonyl- glycyl- glutamyl- asparaginyl- histidylarginineIBA 07/2017 - 03/2006
2	Angiotensin IIIBA 01/2020 - 03/2015
2	Endothelins (Endothelin)IBA 01/2020 - 03/2015
2	Amyloid beta-PeptidesIBA 07/2017 - 03/2006
2	Biomarkers (Surrogate Marker)IBA 02/2014 - 09/2012
2	Neuroprotective AgentsIBA 03/2007 - 07/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Ibotenic AcidIBA 07/2017
1	AmidesIBA 07/2017
1	Nootropic Agents (Nootropics)IBA 07/2017
1	Natriuretic PeptidesIBA 03/2015
1	Anti-Idiotypic AntibodiesIBA 09/2012
1	Nerve Growth Factors (Neurotrophins)IBA 07/2011
1	Excitatory Amino Acid AntagonistsIBA 01/2011
1	N-Methylaspartate (NMDA)IBA 01/2011
1	Protein Synthesis InhibitorsIBA 11/2007
1	Choline (Choline Chloride)IBA 03/2007
1	N-acetylaspartate (N-acetyl aspartate)IBA 03/2007
1	Succinic Acid (Succinate)IBA 03/2007
1	Dihydrotestosterone (Androstanolone)IBA 07/2006
1	Muramidase (Lysozyme)IBA 01/2004
1	Amyloid (Amyloid Fibrils)IBA 01/2004

Therapy/Procedure

1	Ligation 03/2007